找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Data Monitoring in Clinical Trials; A Case Studies Appro David L. DeMets,Curt D. Furberg,Lawrence M. Friedm Book 2006 Springer-Verlag New Y

[复制链接]
楼主: hexagon
发表于 2025-3-27 00:57:52 | 显示全部楼层
The Essentials of Nursing Management Seriesomparing candesartan with placebo in patients with chronic heart failure (CHF) who (1) were intolerant to angiotensin converting enzyme (ACE)-inhibitor and had left ventricular ejection fraction (LVEF) ≤ 40%, (2)) were on ACE-inhibitor and had LVEF ≤ 40% or (3)) had LVEF > 40%. CHARM provides an int
发表于 2025-3-27 04:04:50 | 显示全部楼层
The Essentials of Nursing Management Seriesmplex process. It may involve, among other things, the need to (1) determine whether the observed treatment differences are likely to represent real effects and are not due to chance; (2) weigh the importance of different response variables, some possibly trending in favor of the treatment and some
发表于 2025-3-27 08:06:37 | 显示全部楼层
The Patient-Surgeon Relationships with a recent myocardial infarction would reduce the incidence of sudden death and total mortality, using three drugs known to suppress cardiac arrhythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for even
发表于 2025-3-27 10:48:31 | 显示全部楼层
Communication with Young Peoplestudies with milrinone, a cyclic AMP-enhancing positive inotropic agent. Earlier studies had shown positive effects of milrinone on cardiac function and exercise performance in patients with chronic heart failure. To determine the effect of milrinone on mortality, patients with severe chronic heart
发表于 2025-3-27 14:22:27 | 显示全部楼层
发表于 2025-3-27 21:09:37 | 显示全部楼层
发表于 2025-3-27 21:58:32 | 显示全部楼层
发表于 2025-3-28 02:15:53 | 显示全部楼层
The Patient-Surgeon Relationshipythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for events had been observed with an unexpected but dramatic increase in sudden death and total mortality in those patients receiving two of the active therapies. Later, the third drug was also discontinued.
发表于 2025-3-28 10:04:55 | 显示全部楼层
发表于 2025-3-28 13:23:52 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-17 06:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表